Implantica Successfully Completes MDSAP Recertification Audit

Contributed by: PR Newswire

Tags

Implantica

More Like This

Implantica announces continuing progress in modular PMA application to FDA for RefluxStop™

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica announces U.S. FDA has provided feedback on the final RefluxStop® PMA submission, Module 3

Implantica finishes new multi-cavity production tool for RefluxStop® to support manufacturing ramp-up in the U.S. pending FDA approval

Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop® for US market approval

Implantica Announces Real-World Clinical Data from over 200 Patients treated across five RefluxStop™ Centers in Europe Presented at SAGES in Cleveland

Implantica ramps-up production with 10,000 RefluxStop® units in preparation for U.S. launch, pending FDA PMA approval

Implantica's RefluxStop™ garners strong interest at SAGES